TTY Biopharm Co (ROCO:4105) Cyclically Adjusted FCF per Share: NT$5.11 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4105 TTY Biopharm Co Ltd ROCO:4105
85 GF Score
Price NT$76.10
GF Value NT$87.97
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is TTY Biopharm Co Cyclically Adjusted FCF per Share?

TTY Biopharm Co ROCO:4105 -0.65% 85 Cyclically Adjusted FCF per Share is NT$5.11 as of Mar. 2026. GuruFocus rates ROCO:4105 with a GF Score™ of 85/100 and a GF Value™ of NT$87.97 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

TTY Biopharm Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was NT$2.111. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$5.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, TTY Biopharm Co's average Cyclically Adjusted FCF Growth Rate was 9.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 14.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of TTY Biopharm Co was 26.30% per year. The lowest was 14.30% per year. And the median was 25.60% per year.

As of today (2026-08-07), TTY Biopharm Co's current stock price is NT$76.10. TTY Biopharm Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was NT$5.11. TTY Biopharm Co's Cyclically Adjusted Price-to-FCF of today is 14.89.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of TTY Biopharm Co was 62.78. The lowest was 14.11. And the median was 23.62.


TTY Biopharm Co  (ROCO:4105) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

TTY Biopharm Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=76.10/5.11
=14.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of TTY Biopharm Co was 62.78. The lowest was 14.11. And the median was 23.62.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


TTY Biopharm Co Cyclically Adjusted FCF per Share Related Terms


TTY Biopharm Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for TTY Biopharm Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTY Biopharm Co Cyclically Adjusted FCF per Share Chart

TTY Biopharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.64 3.33 3.79 4.45 4.97

TTY Biopharm Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.67 4.67 4.76 4.97 5.11

ROCO:4105 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTY Biopharm Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's Cyclically Adjusted Price-to-FCF falls into.


ROCO:4105
85GF Score
TTY Biopharm Co Ltd ROCO:4105
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TTY Biopharm Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TTY Biopharm Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.111/330.2130*330.2130
=2.111

Current CPI (Mar. 2026) = 330.2130.

TTY Biopharm Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 1.036 241.018 1.419
201609 0.937 241.428 1.282
201612 1.335 241.432 1.826
201703 0.712 243.801 0.964
201706 0.804 244.955 1.084
201709 0.791 246.819 1.058
201712 1.307 246.524 1.751
201803 1.626 249.554 2.152
201806 0.213 251.989 0.279
201809 0.465 252.439 0.608
201812 1.661 251.233 2.183
201903 0.949 254.202 1.233
201906 0.666 256.143 0.859
201909 1.705 256.759 2.193
201912 1.254 256.974 1.611
202003 0.884 258.115 1.131
202006 -0.253 257.797 -0.324
202009 -0.060 260.280 -0.076
202012 0.811 260.474 1.028
202103 1.281 264.877 1.597
202106 1.067 271.696 1.297
202109 0.365 274.310 0.439
202112 2.047 278.802 2.424
202203 1.177 287.504 1.352
202206 0.483 296.311 0.538
202209 1.486 296.808 1.653
202212 1.275 296.797 1.419
202303 0.858 301.836 0.939
202306 0.768 305.109 0.831
202309 0.145 307.789 0.156
202312 2.185 306.746 2.352
202403 1.311 312.332 1.386
202406 0.299 314.175 0.314
202409 0.286 315.301 0.300
202412 2.977 315.605 3.115
202503 1.428 319.799 1.475
202506 0.964 322.561 0.987
202509 1.087 324.800 1.105
202512 2.978 324.054 3.035
202603 2.111 330.213 2.111

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$5.11 mean?
TTY Biopharm Co (ROCO:4105) has a Cyclically Adjusted FCF per Share of NT$5.11 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on TTY Biopharm Co and its competitors.
Is TTY Biopharm Co's Cyclically Adjusted FCF per Share too high?
TTY Biopharm Co's current Cyclically Adjusted FCF per Share is NT$5.11. Overall, TTY Biopharm Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTY Biopharm Co's Cyclically Adjusted FCF per Share compare to ZTS?
TTY Biopharm Co's Cyclically Adjusted FCF per Share of NT$5.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on TTY Biopharm Co and its competitors. TTY Biopharm Co's current Cyclically Adjusted FCF per Share is NT$5.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTY Biopharm Co stock overvalued right now?
Based on GuruFocus' analysis, TTY Biopharm Co (ROCO:4105) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.97, compared to a current price of NT$76.10 — trading 13.5% below its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$5.11. TTY Biopharm Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For TTY Biopharm Co (ROCO:4105), the current Cyclically Adjusted FCF per Share is NT$5.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TTY Biopharm Co (ROCO:4105) Overvalued in 2026?

Based on GuruFocus' analysis, TTY Biopharm Co stock appears to be undervalued. The current stock price of NT$76.10 is trading 13.5% below its estimated GF Value™ of NT$87.97. GuruFocus considers TTY Biopharm Co to be Modestly Undervalued.

Key valuation signals for ROCO:4105:

  • Cyclically Adjusted FCF per Share: NT$5.11
  • GF Value™: NT$87.97 vs. price of NT$76.10 (13.5% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4105 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TTY Biopharm Co Business Description

Address No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503
TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segments includes Oncology Business unit, Health Care Business unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business unit segment. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in America. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.
85GF Score

Get the complete analysis for ROCO:4105

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$76.10
Price
NT$87.97
GF Value